C4 Therapeutics, Inc. announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 146,880 shares of the Company’s common stock to one new employee, with the grant made on April 29, 2024.
April 29, 2024
· 1 min read